Vaccine antigen preparation for human or non-clinical studies can be prepared in our facility which is suitable for drug development and contract manufacturing. Utilising more than 15 years of contract manufacturing experience, LuinaBio scientists have the knowledge, training and experience to ensure a successful outcome to any biomanufacturing project using a variety of approaches.

  • Live, attenuated vaccines
  • Inactivated vaccines
  • Subunit vaccines
  • Toxoid vaccines
  • DNA vaccines
  • Recombinant vector vaccines

We are also able to, under our TGA/APVMA licenses, prepare finished product to international GMP standards and can provide comprehensive manufacturing solutions for the veterinary, biological and small molecule market, including storage and distribution. Our past projects include recombinant proteins, whole cell vaccines, viral vaccines, purified plant extracts, pro-biotics and synthetic molecules for pre-clinical, phase 1 to 3 human clinical trials, and commercial veterinary products for clients both within Australia and internationally in the US, New Zealand and Asia.

We are able to offer the following capability and service:

  • Dedicated containment area
  • Flask or fermentation for recombinant vaccines
  • Attenuation or killed preparations
  • Antigen capture and stabilization
  • Documentation and support services

LuinaBio wants to be your trusted partner in manufacturing. We are cost competitive, and have the resources and expertise to handle all stages of manufacturing from pre-clinical to the marketplace.